Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan.
Department of Pathology, Rehman Medical Institute, Peshawar, Pakistan.
PLoS One. 2018 Oct 19;13(10):e0205508. doi: 10.1371/journal.pone.0205508. eCollection 2018.
Esophageal squamous cell carcinoma (ESCC) is one of the aggressive malignancies and mechanisms underlying its pathogenesis remain unclear. Cyclooxygenase-2 (COX-2) enzyme system plays a crucial role in many gastrointestinal malignancies and is an important regulator of cell growth, proliferation, apoptosis, differentiation and transformation. More precise outcome of COX-2 in ESCC is less investigated. In this study we investigated the risk factors of ESCC and expression of COX-2 in Carcinoma in situ (CIS) and ESCC compared to normal esophageal mucosa. ESCC relationship to clinico-pathological parameters using immunohistochemistry was also part of this investigation. Current study was conducted in the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan. A total of 69 diagnosed patients of ESCC, both Pakistanis and Afghans were enrolled. Various risk factors associated with ESCC were recorded. Mean age at the time of diagnosis was 55 years. Out of 69 patients of ESCC 46 (67%) were users of dipping tobacco (Naswar). Expression of COX-2 was determined in normal esophageal mucosa, CIS and invasive ESCC using Immunohistochemistry (IHC). Differences of mean were computed using ANOVA followed by applying Post Hoc test. Patients were categorized as positive with high expression or negative with low to nil expression. ANOVA showed large differences in expression of COX-2 in normal healthy mucosa compared with CIS and ESCC with the mean difference of -9.529 and -7.370 respectively, p-value being <.05 at 95% confidence interval (CI). No significant difference was noticed in the expression of COX-2 in CIS compared with ESCC with p-value >.05 at 95% CI. Our complete cohort (23-85 years) showed statistically significant difference in the expression of COX-2 gene in ESCC and CIS tissue samples compared with normal healthy mucosa. Results of this study indicate that over-expression of COX-2 is positively associated with ESCC.
食管鳞状细胞癌 (ESCC) 是一种侵袭性恶性肿瘤,其发病机制尚不清楚。环氧化酶-2 (COX-2) 酶系统在许多胃肠道恶性肿瘤中发挥着关键作用,是细胞生长、增殖、凋亡、分化和转化的重要调节因子。COX-2 在 ESCC 中的更精确作用尚待研究。本研究旨在探讨 ESCC 的危险因素及 COX-2 在原位癌 (CIS) 和 ESCC 中的表达,并与正常食管黏膜进行比较。本研究还通过免疫组织化学方法探讨了 COX-2 与 ESCC 的临床病理参数的关系。本研究在巴基斯坦白沙瓦的开伯尔医学大学基础医学研究所进行。共纳入 69 例巴基斯坦和阿富汗 ESCC 患者。记录了与 ESCC 相关的各种危险因素。诊断时的平均年龄为 55 岁。在 69 例 ESCC 患者中,有 46 例(67%)使用鼻烟(那斯尔)。采用免疫组织化学法(IHC)检测正常食管黏膜、CIS 和浸润性 ESCC 中 COX-2 的表达。采用方差分析(ANOVA)比较均值差异,然后应用事后检验。将患者分为 COX-2 高表达阳性和低表达或无表达阴性。ANOVA 显示,COX-2 在正常健康黏膜与 CIS 和 ESCC 之间的表达存在显著差异,平均差异分别为-9.529 和-7.370,p 值均<0.05,置信区间(CI)为 95%。CIS 与 ESCC 之间 COX-2 表达无显著差异,p 值>0.05,95%CI。我们的全队列(23-85 岁)显示,ESCC 和 CIS 组织样本中 COX-2 基因的表达与正常健康黏膜有统计学显著差异。本研究结果表明,COX-2 的过表达与 ESCC 呈正相关。